{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:49:08Z","timestamp":1766400548868,"version":"build-2065373602"},"reference-count":118,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T00:00:00Z","timestamp":1327363200000},"content-version":"vor","delay-in-days":10187,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1984,3,4]]},"abstract":"<jats:p>Ceftizoxime is an iminomethoxy aminothiazolyl cephalosporin that inhibits a wide variety of aerobic, anaerobic gram\u2010positive and gram\u2010negative bacteria. The majority of Enterobacteriaceae are inhibited by \u2264 1 \u03bcg\/ml as are streptococcal species with the exception of <jats:italic>Streptococcus faecalis. Staphylococcus aureus<\/jats:italic> are inhibited by 3\u20138 \u03bcg\/ml, while methicillin\u2010resistant <jats:italic>S. aureus<\/jats:italic> are resistant. <jats:italic>Bacteroides fragilis<\/jats:italic> are inhibited by 16\u201364 \u03bcg\/ml. It inhibits <jats:italic>Pseudomonas aeruginosa<\/jats:italic> at usually achievable concentrations. Ceftizoxime is overall similar in antibacterial activity to cefotaxime and moxalactam. Ceftizoxime is not hydrolyzed by common plasmid and chromosomal \u03b2\u2010lactamases. Serum levels of ceftizoxime after intramuscular and intravenous injection are similar to those of cefotaxime and moxalactam. The half\u2010life is 1.6 to 1.9 hours in normal individuals. The compound is not metabolized and is cleared from the body by glomerular filtration. Ceftizoxime enters most body fluids, including the cerebrospinal fluid, to produce therapeutic concentrations against clinically important bacteria. Ceftizoxime accumulates in the presence of renal failure, but it is removed from the body by hemodialysis and peritoneal dialysis. Ceftizoxime has proved to be an effective chemotherapeutic agent when used as treatment for pneumonia, urinary tract infections, osteomyelitis, septic arthritis, meningitis, peritonitis, gonorrhea, including penicillinase\u2010producing isolates, and gynecological infections. No major adverse reactions have been associated with the use of ceftizoxime and it has produced neither disulfram\u2010like reactions nor bleeding.<\/jats:p>","DOI":"10.1002\/j.1875-9114.1984.tb03313.x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T15:07:44Z","timestamp":1450278464000},"page":"47-58","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Ceftizoxime: A Beta\u2010Lactamase\u2010Stable, Broad\u2010Spectrum Cephalosporin"],"prefix":"10.1002","volume":"4","author":[{"given":"Harold C.","family":"Neu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)90333-6"},{"key":"e_1_2_1_3_2","first-page":"85","volume-title":"New beta\u2010lactam antibiotics: a review from chemistry to clinical efficacy of the new cephalosporins","author":"Neu HC.","year":"1982"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.Supplement_2.S319"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/med.2610010202"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.11"},{"key":"e_1_2_1_7_2","first-page":"65","volume-title":"New beta\u2010lactam antibiotics: a review from chemistry to clinical efficacy of the new cephalosporins","author":"Nishida M.","year":"1982"},{"issue":"4","key":"e_1_2_1_8_2","first-page":"483","article-title":"Antibacterial activity of ceftizoxime, a beta\u2010lactamase\u2010stable cephalosporin","volume":"17","author":"Fu KP","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.16.5.540"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.32.1319"},{"issue":"10","key":"e_1_2_1_11_2","first-page":"1662","article-title":"Laboratory evaluation of ceftizoxime, a new parenteral cephalosporin","volume":"30","author":"Kamimura T.","year":"1980","journal-title":"Arzneim Forsch"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.21.2.344"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/mim.1982.26.7.617"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01640880"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.2.242"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1982.69"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.17.3.397"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.16.5.549"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/7.6.673"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.2.226"},{"key":"e_1_2_1_21_2","first-page":"113","volume-title":"New trends in antibiotics: research and therapy","author":"Richmond MH.","year":"1981"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.6.760"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.63"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.25"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.4.545"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.21.2.204"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.3.397"},{"key":"e_1_2_1_28_2","first-page":"255","volume-title":"Current chemotherapy and infectious disease","author":"Takaya T.","year":"1980"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.3.332"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.5.683"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.5.600"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.6.852"},{"issue":"5","key":"e_1_2_1_33_2","first-page":"764","article-title":"Susceptibility of the species of genus Bacteroides recently isolated from clinical specimens to 20 antimicrobial agents","volume":"31","author":"Nasu M.","year":"1981","journal-title":"Arzneim Forsch"},{"key":"e_1_2_1_34_2","first-page":"493","volume-title":"Beta\u2010lactam antibiotics: mode of action, new developments and future prospects","author":"George WL","year":"1981"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.45"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.3.393"},{"key":"e_1_2_1_37_2","first-page":"47","volume-title":"New beta\u2010lactam antibiotics: a review from chemistry to clinical efficacy of the new cephalosporins","author":"Bush K.","year":"1982"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.1.136"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.51"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.57"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.63"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.69"},{"issue":"10","key":"e_1_2_1_43_2","first-page":"1680","article-title":"General pharmacology of ceftizoxime sodium","volume":"30","author":"Honda F.","year":"1980","journal-title":"Arzneim Forsch"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.3.366"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1981.tb01738.x"},{"issue":"1","key":"e_1_2_1_46_2","first-page":"47","article-title":"Pharmacokinetic, antibacterial and clinical studies of ceftizoxime in pediatrics","volume":"35","author":"Iwai N.","year":"1982","journal-title":"Jpn J Antibiot"},{"issue":"1","key":"e_1_2_1_47_2","first-page":"91","article-title":"Pharmacokinetic and clinical studies of ceftizoxime","volume":"35","author":"Okada T.","year":"1982","journal-title":"Jpn J Antibiot"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1982.tb05704.x"},{"issue":"4","key":"e_1_2_1_49_2","first-page":"416","article-title":"Pharmacokinetics of ceftizoxime with or without probenecid","volume":"32","author":"Adam D.","year":"1982","journal-title":"Arzneim Forsch"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1982.69"},{"key":"e_1_2_1_51_2","first-page":"157","volume-title":"New beta\u2010lactam antibiotics: a review from chemistry to clinical efficacy of the new cephalosporins","author":"Luthy R.","year":"1982"},{"key":"e_1_2_1_52_2","first-page":"17","article-title":"Metabolism and pharmacokinetics of the newer cephalosporins: cefotaxime, ceftizoxime, ceftriaxone, ceftazidime, cefoperazone, moxalactam and cefsulodin","volume":"1","author":"Coombes JD.","year":"1982","journal-title":"New beta-lactam antibiotics: a review from chemistry to clinical efficacy of the new cephalosporins"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.22.2.308"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.22.5.878"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.91"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.99"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.311"},{"issue":"3","key":"e_1_2_1_58_2","first-page":"185","article-title":"Pharmacokinetics of ceftizoxime in patients undergoing hemodialysis","volume":"4","author":"Shah PM","year":"1982","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.22.2.308"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.24.2.151"},{"key":"e_1_2_1_61_2","first-page":"753A","article-title":"Pharmacokinetics and peritoneal clearance of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis","volume":"30","author":"Gross ML","year":"1982","journal-title":"Clin Res"},{"key":"e_1_2_1_62_2","first-page":"249","article-title":"Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis","volume":"3","author":"Blair AD","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_2_1_63_2","first-page":"265","article-title":"Ceftizoxime exchange through the peritoneal membrane in renal patients","volume":"33","author":"Somani P.","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.24.2.237"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.105"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.117"},{"issue":"5","key":"e_1_2_1_67_2","first-page":"277","article-title":"In\u2010vitro antibacterial activity pharmacological study following intramuscular injection sputum level and clinical evaluation on ceftizoxime","volume":"28","author":"Nakagawa K.","year":"1980","journal-title":"Chemotherapy"},{"issue":"4","key":"e_1_2_1_68_2","first-page":"869","article-title":"Ceftizoxime","volume":"35","author":"Shimizu K.","year":"1982","journal-title":"Jpn J Antibiot"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.121"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.141"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01816728"},{"issue":"1","key":"e_1_2_1_72_2","first-page":"33","article-title":"Pharmacokinetic and clinical studies of ceftizoxime in pediatrics","volume":"35","author":"Nakazawa S.","year":"1982","journal-title":"Jpn J Antibiot"},{"issue":"1","key":"e_1_2_1_73_2","first-page":"113","article-title":"Pharmacokinetics and clinical effects of ceftizoxime in pediatrics","volume":"35","author":"Motohiro T.","year":"1982","journal-title":"Jpn J Antibiot"},{"issue":"12","key":"e_1_2_1_74_2","first-page":"1571","article-title":"Laboratory and clinical studies of ceftizoxime in otolaryngology","volume":"34","author":"Hatano T.","year":"1981","journal-title":"Jpn J Antibiot"},{"issue":"2","key":"e_1_2_1_75_2","first-page":"399","article-title":"Experimental and clinical studies on ceftizoxime in the field of oral surgery","volume":"35","author":"Tsushima T.","year":"1982","journal-title":"Jpn J Antibiot"},{"issue":"9","key":"e_1_2_1_76_2","first-page":"2252","article-title":"Pharmacological and clinical studies of ceftizoxime in obstetric and gynecological infections","volume":"35","author":"Hayasaki M.","year":"1982","journal-title":"Jpn J Antibiot"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-3-408"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.151"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.159"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.167"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.175"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.183"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.191"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.193"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.201"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.209"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.215"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.223"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.227"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.229"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.237"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.241"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.247"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.253"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.261"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.265"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.273"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.281"},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.289"},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.293"},{"key":"e_1_2_1_101_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.297"},{"key":"e_1_2_1_102_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.303"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.311"},{"key":"e_1_2_1_104_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.327"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.339"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.135"},{"key":"e_1_2_1_107_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-98-3-415_2"},{"key":"e_1_2_1_108_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198306000-00013"},{"key":"e_1_2_1_109_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.suppl_C.129"},{"issue":"1","key":"e_1_2_1_110_2","first-page":"1","article-title":"Clinical evaluation of ceftizoxime in the pediatric infections","volume":"35","author":"Mashiko J.","year":"1982","journal-title":"Jpn J Antibiot"},{"issue":"1","key":"e_1_2_1_111_2","first-page":"9","article-title":"Laboratory and clinical studies on ceftizoxime in pediatrics","volume":"35","author":"Toyonaga Y.","year":"1982","journal-title":"Jpn J Antibiot"},{"issue":"1","key":"e_1_2_1_112_2","first-page":"33","article-title":"Pharmacokinetic and clinical studies of ceftizoxime in pediatrics","volume":"35","author":"Nakazawa S.","year":"1982","journal-title":"Jpn J Antibiot"},{"issue":"1","key":"e_1_2_1_113_2","first-page":"47","article-title":"Pharmacokinetic, antibacterial and clinical studies of ceftizoxime in pediatrics","volume":"35","author":"Iwai N.","year":"1982","journal-title":"Jpn J Antibiot"},{"issue":"1","key":"e_1_2_1_114_2","first-page":"81","article-title":"Clinical experience with ceftizoxime in pediatrics","volume":"35","author":"Hosoda T.","year":"1982","journal-title":"Jpn J Antibiot"},{"issue":"1","key":"e_1_2_1_115_2","first-page":"105","article-title":"Clinical studies on ceftizoxime in pediatric field","volume":"35","author":"Yoshida T.","year":"1982","journal-title":"Jpn J Antibiot"},{"issue":"1","key":"e_1_2_1_116_2","first-page":"113","article-title":"Pharmacokinetics and clinical effects of ceftizoxime in pediatrics","volume":"35","author":"Motohiro T.","year":"1982","journal-title":"Jpn J Antibiot"},{"issue":"1","key":"e_1_2_1_117_2","first-page":"137","article-title":"Clinical studies of ceftizoxime in children","volume":"35","author":"Kobayashi Y.","year":"1982","journal-title":"Jpn J Antibiot"},{"issue":"1","key":"e_1_2_1_118_2","first-page":"152","article-title":"Antibacterial pharmacokinetics and clinical studies of ceftizoxime in infections in children","volume":"35","author":"Ogawa A.","year":"1982","journal-title":"Jpn J Antibiot"},{"issue":"1","key":"e_1_2_1_119_2","first-page":"160","article-title":"Laboratory and clinical studies of ceftizoxime in pediatrics","volume":"35","author":"Sekiguchi T.","year":"1982","journal-title":"Jpn J Antibiot"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1984.tb03313.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1984.tb03313.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1875-9114.1984.tb03313.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T16:08:59Z","timestamp":1761062939000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/j.1875-9114.1984.tb03313.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,3,4]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1984,3,4]]}},"alternative-id":["10.1002\/j.1875-9114.1984.tb03313.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1875-9114.1984.tb03313.x","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[1984,3,4]]},"assertion":[{"value":"2012-01-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}